Final statements and closing remarks
The entire group of world experts will give take-home messages. Guided by experts in fluorescence and pathology, we can try to achieve an ultrastaging to improve results for our patients. This increased accuracy has an expected financial effect of lower spending, due to better oncologic outcomes and decreased morbidity (thanks to the perfusion evaluation). This is the beginning of an amazing technology, and we will be seeing new targets and indications in the future.